An International Physical Activity and Public Health Research Agenda to Inform Coronavirus Disease (COVID)-19 Policies and Practices

Summarized for GP RED by the authors James Sallis, Deepti Adlakha, Adewale Oyeyemi, and Deborah Salvo

Report (2020)

Authors

Sallis University of California, Australian Catholic University
Adlakha Queen's University Belfast
Oyeyemi University of Maiduguri
Salvo Washington University in St. Louis
Affiliation
External organisation
More Info
expand_more

Published Date

2020

Language

English

Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Affiliation

External organisation

Abstract

What if there was a single therapy available with strong evidence that it:

a) boosts immune function and reduces inflammation (the most important physiological mechanisms determining the severity of COVID-19 infections);
b) prevents and treats most of the chronic diseases that increase risk of severe COVID-19 infections; and
c) can reduce anxiety and depression produced by the health, economic, and social isolation stress of the pandemic?

Every health care professional would demand urgent production of that agent to be prescribed to every patient infected with the coronavirus, and the world would demand that agent be given prophylactically to everyone.